tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Matthew Taylor, 126 are a BUY (63%), 59 are a HOLD (29.5%), 15 are a SELL (7.5%).
Analyst Matthew Taylor, currently employed at JEFFERIES, carries an average stock price target met ratio of 67.66% that have a potential upside of 18.45% achieved within 182 days.
Matthew Taylor’s has documented 379 price targets and ratings displayed on 35 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ABT, Abbott Laboratories at 17-Jul-2025.
Analyst best performing recommendations are on INMD (INMODE LTD).
The best stock recommendation documented was for TNDM (TANDEM DIABETES CARE) at 11/27/2018. The price target of $36 was fulfilled within 2 days with a profit of $2.71 (8.14%) receiving and performance score of 40.7.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$145
$10.41 (7.73%)
$137
2 months 21 days ago
(17-Jul-2025)
13/14 (92.86%)
$21.33 (17.25%)
369
Buy
$141
$6.41 (4.76%)
$142
2 months 21 days ago
(17-Jul-2025)
18/22 (81.82%)
$17.33 (14.01%)
376
Buy
$145
$10.41 (7.73%)
$139
2 months 21 days ago
(17-Jul-2025)
6/9 (66.67%)
$21.33 (17.25%)
753
Hold
$140
$5.41 (4.02%)
$130
2 months 23 days ago
(15-Jul-2025)
5/6 (83.33%)
$8.26 (6.27%)
125
Hold
$137
$2.41 (1.79%)
$127
2 months 24 days ago
(14-Jul-2025)
18/20 (90%)
$5.51 (4.19%)
452
Which stock is Matthew Taylor is most bullish on?
Which stock is Matthew Taylor is most reserved on?
What Year was the first public recommendation made by Matthew Taylor?
